Video

It's Never Too Early For Innovators To Meet With A CDMO

Starting conversations with your CDMO as early as possible can help enable faster onboarding and sharing of information to facilitate a successful tech transfer. For sponsor companies using a unique technology, earlier conversations allow your CDMO to establish the appropriate type of platform within their facility to be able to effectively utilize it during the drug development process.

Advanced lead time is also critical for some equipment, consumables, raw materials, chemicals, and components that present ordering hurdles. Examine how the earlier your CDMO is able to understand your process, the better prepared it will be to support development and clinical or commercial manufacturing.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online